GlassScriptPhysician profile
Christopher Michael Jones
NPI 1598812315
$33,691.11
in general payments reported to CMS, 2019-2025
21 companies · $579 in 2025
The $579 reported for 2025 was more than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,260 · 2020: $14K · 2021: $3,746 · 2022: $6,682 · 2023: $623 · 2024: $137 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.27 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veloxis Pharmaceuticals, INC. | $26,925.36 | 2019-2024 | Envarsus |
| Intuitive Surgical, INC. | $3,811.38 | 2020-2022 | |
| Stryker Corporation | $1,304.95 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $218.93 | 2019 | |
| Medtronic USA, INC. | $198.85 | 2020 | |
| Paragonix Technologies, INC. | $169.99 | 2025 | |
| Mallinckrodt Hospital Products INC. | $140.48 | 2021-2025 | Terlivaz |
| Pacira Pharmaceuticals Incorporated | $124.74 | 2020 | |
| Abbvie INC. | $122.41 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $119.70 | 2024 | Farxiga |
| Scpharmaceuticals INC. | $119.12 | 2025 | |
| Davol INC. | $103.44 | 2023 | Phasix Mesh |
| Ferring Pharmaceuticals INC. | $79.32 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.17 | 2019-2023 | Xifaxan |
| Amgen INC. | $48.99 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $41.78 | 2025 | Ecc Solutions, Mcot |
| Medtronic, INC. | $31.23 | 2021 | |
| Biosense Webster, INC. | $31.23 | 2020-2022 | |
| Orthogenrx INC. | $21.61 | 2019 | |
| Pfizer INC. | $16.43 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.